Development of new generation influenza vaccines: Recipes for success?

E.S. Pronker, E. Claassen, A.D.M.E. Osterhaus

Research output: Contribution to JournalArticleAcademicpeer-review


As infectious diseases cause approximately 25% of the annual global mortality, vaccines are found to be a time proven and promising response to infectious disease need. However, like for pharmaceutical small molecules, vaccine development is lengthy, risky and resource demanding. Faced with an attrition rate estimated around 80%, key opinion leaders were interviewed with the question: is there a recipe for success? © 2012 Elsevier Ltd.
Original languageEnglish
Pages (from-to)7344-7347
Issue number51
Publication statusPublished - 2012


Dive into the research topics of 'Development of new generation influenza vaccines: Recipes for success?'. Together they form a unique fingerprint.

Cite this